Pamela Stephenson Gemini Therapeutics, Inc. (GMTX) insider trading activity

Pamela Stephenson is Chief Commercial Officer of Gemini Therapeutics, Inc. . Currently has a direct ownership of 36,666 shares of GMTX, which is worth approximately $893,550. The most recent transaction as insider was on Feb 26, 2024, when has been sold 36,666 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 36.7K

0% 3M change

n/a 12M change

Total Value Held $893,550

Pamela Stephenson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Feb 26 2024	BUY Grant, award, or other acquisition	-	36,666 Added 50.0%	36,666 Common Stock

Also insider at

ALBO

ALBIREO PHARMA, INC. Healthcare

Chief Commercial Officer

ZYNE

Zynerba Pharmaceuticals, Inc. Healthcare